ANVS
ANVS
Last
$1.21
Day
+3.4%
1y
-46.8%
5y
-96.1%
52w
-78.7%
SPY YTD
+13.3%
Sec
—
Earnings
2026-11-1132d
EMA 21
1.26
EMA 50
1.43
EMA 200
2.01
20d high
-18.2%
5y high
-97.1%
5y range
0th
Positions held
Your positionsANVS isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-12
Hold
avoid
Signal
Sell
Target
$1.33
Stop
$1.04
Stop distance
14.1%
Target vs last
+9.9%
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-08 · Annovis Bio (ANVS) Loses 26.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
2026-09-03 · Annovis Bio Targets March 2027 Alzheimer’s Readout, Prepares Rolling NDA
2026-08-25 · Annovis to Host Corporate Update Webinar on September 2, 2026
2026-08-14 · Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results
2026-08-06 · The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight
Price (daily)
Full chart · RSI · MACD · patternsANVS · daily-1.7% over 14 sessions
Close EMA21 EMA50 EMA200